Short Interest in Addus HomeCare Co. (NASDAQ:ADUS) Drops By 7.9%

Addus HomeCare Co. (NASDAQ:ADUS) was the recipient of a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 501,300 shares, a drop of 7.9% from the January 15th total of 544,200 shares. Based on an average daily volume of 148,000 shares, the days-to-cover ratio is presently 3.4 days.

Addus HomeCare Trading Down 2.0 %

ADUS opened at $113.22 on Monday. The stock’s 50-day moving average price is $126.04 and its 200 day moving average price is $127.12. Addus HomeCare has a 12-month low of $85.94 and a 12-month high of $136.72. The firm has a market cap of $2.05 billion, a price-to-earnings ratio of 25.91, a PEG ratio of 1.55 and a beta of 1.00.

Insider Transactions at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,750 shares of company stock worth $4,930,750 over the last three months. 4.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Addus HomeCare

Hedge funds have recently bought and sold shares of the company. Quarry LP acquired a new position in Addus HomeCare during the 3rd quarter worth about $28,000. Natixis lifted its stake in Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company’s stock worth $31,000 after acquiring an additional 132 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock worth $35,000 after acquiring an additional 214 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after acquiring an additional 366 shares in the last quarter. Finally, Parkside Financial Bank & Trust lifted its stake in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after acquiring an additional 148 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Macquarie restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer lifted their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Finally, Stephens boosted their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $134.22.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.